| Stage | HLNE | % of rev | LCII | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $204M | 100.00% | $969M | 100.00% | LCII ×4.74 |
| Gross profit | $127M | 62.11% | $301M | 31.09% | HLNE +31.0pp |
| Operating income | $86M | 42.23% | $96M | 9.91% | HLNE +32.3pp |
| Pre-tax income | $179M | 87.37% | $90M | 9.31% | HLNE +78.1pp |
| Net income | $149M | 72.85% | $67M | 6.93% | HLNE +65.9pp |
| Stage | HLNE | LCII | Gap · A − B |
|---|---|---|---|
| Revenue | $204M100.00% | $969M100.00% | LCII ×4.74 |
| Gross profit | 62.11%$127M | 31.09%$301M | HLNE +31.0pp |
| Operating income | 42.23%$86M | 9.91%$96M | HLNE +32.3pp |
| Pre-tax income | 87.37%$179M | 9.31%$90M | HLNE +78.1pp |
| Net income |
| 72.85%$149M |
| 6.93%$67M |
| HLNE +65.9pp |
No shared counterparties.